A Case of Imatinib-mesylate associated Hypersensitivity Pneumonitis |
Lee, Jae Wong
(Department of Internal Medicine, College of Medicine, Yeungnam University)
Kim, Hye Jin (Department of Internal Medicine, College of Medicine, Yeungnam University) Kim, Kyu Jin (Department of Internal Medicine, College of Medicine, Yeungnam University) Shin, Kyeong Cheol (Department of Internal Medicine, College of Medicine, Yeungnam University) Hong, Yeong Hoon (Department of Internal Medicine, College of Medicine, Yeungnam University) Chung, Jin Hong (Department of Internal Medicine, College of Medicine, Yeungnam University) Lee, Kwan Ho (Department of Internal Medicine, College of Medicine, Yeungnam University) |
1 | Yokoyama T, Miyazawa K, Kurakawa E, Nagate A, Shimamoto T, Iwaya K, et al. Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration. Leukemia 2004;18:645-6 DOI ScienceOn |
2 | Takashima M, Igaki N, Matsuda T, Ohyama M, Kanda S, Tamada F, et al. Malignant gastrointestinal stromal tumor of small intestine complicated with pulmonary tuberculosis during treatment with imatinib mesylate. Intern Med 2005;44:114-9 DOI ScienceOn |
3 | van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, et al. Safety and efficacy of imatinib in metastatic gastrointestinal stromal tumors: a phase I study. Lancet 2001;358: 1421-3 DOI ScienceOn |
4 | Rankin C, von Mehren M, Blanke C. Dose effect of imatinib in patients with metastatic GIST-a phase III sarcoma group study S0033 [Abstract]. Proc Annu Meet Am Soc Clin Oncol 2004:9005 |
5 | Rasado MF, Donna E, Ahn YS. Challenging problems in advanced malignancy: case 3. imatinib mesylateinduced interstitial pneumonitis. J Clin Oncol 2003; 21:3171-3 DOI PUBMED |